and exposing these children to a second source of morbidity and mortality. 27 Prophylactic treatment of all patients with an internal CSF diversion, known as an endoscopic third ventriculostomy, at the time of initial tumor resection has been reported to reduce the risk of postresection hydrocephalus from 26.8 to 6%. 27 However, treating all children with posterior fossa tumors this way potentially exposes ~ 70% of patients to an unnecessary procedure that can have significant risks. 3, 15 A preoperative clinical prediction rule for postresection hydrocephalus that identifies high-and low-risk patients would be helpful to optimize the care of these children. The purpose of this study was to develop such a rule.
Methods

Patient Population
The study was approved by the ethics review committees at both participating centers. Between January 1989 and September 2003, we examined 343 consecutive patients ≤ 17 years of age with new, radiologically confirmed, diagnoses of posterior fossa neoplasms at the Hospital for Sick Children in Toronto. None of the children eligible for this study had undergone a preresection shunting procedure (CSF shunt insertion or endoscopic third ventriculostomy), and patients with preexisting unrelated hydrocephalus (for example, from prior trauma) were excluded. Patients who died within 6 months of tumor resection were excluded because they may not have had the same time or opportunity to develop postresection hydrocephalus. The validation cohort was a similarly accrued sample of 111 consecutive children with posterior fossa tumors from the British Columbia Children's Hospital in Vancouver between January 1993 and September 2003.
Potential Predictors and Outcome
Potential predictor variables were identified via a thorough review of previous literature and complemented by a qualitative technique-based pilot study involving 10 pediatric neurosurgeons and 4 pediatric neuroradiologists from across North America. This method used a semistructured interview process and weighting of themes. 2, 9, 23 The purpose of this process was to capture the clinical experience and intuition of experts in the field and translate this information into previously undocumented potential predictors. Potential predictors were then reduced to the final variables to be tested in the model by majority vote of a 3-person panel consisting of a pediatric neurosurgeon (J.M.D.), a pediatric neuroradiologist (D.A.), and a neurosurgery resident (J.R.C.).
Clinical variables were abstracted via chart review. A subgroup of 22.2% of the charts was independently reviewed by a second abstractor, with an error rate of 0.7% using each piece of data as the denominator. Preoperative data were abstracted first, but the postoperative occurrence of hydrocephalus was recorded by the same abstractor. Radiological variables were ascertained from preoperative cerebral CT and MR imaging. These images were reinterpreted by pediatric neuroradiologists at each center who were involved in this study (D.A. and M.S.) and were blinded to all patient data.
Age at tumor diagnosis was dichotomized into 2 groups, those who were ≥ 2 years and those who were < 2 years of age, based on the results of the qualitative interview technique described above. Preoperative lethargy was defined as lethargy, drowsiness, decreased alertness, unresponsiveness, or a Glasgow Coma Scale score of < 14 documented on presentation. The duration of signs or symptoms of raised intracranial pressure was collected from admission histories. Papilledema was defined as a preoperative determination of optic nerve edema by the neurosurgeon or ophthalmologist, as recorded in the patient's chart. The degree of hydrocephalus was recorded qualitatively as none, mild, moderate, or severe. This variable was dichotomized into simpler none/mild and moderate/severe categories in an attempt to further minimize the subjective nature of such a qualitative predictor. Tumor size was measured as the largest diameter of the tumor on any single axial slice of preoperative imaging. Tumor hemorrhage was defined as intra-or peritumoral hemorrhage on admission imaging. Intracranial metastasis included both diffuse leptomeningeal spread and secondary solid disease. Tumor location was measured as the distance between the geometrical center (intersection of 2 largest diameters) of the tumor and the midline.
Predicted tumor pathology was defined as the study radiologists' prediction of tumor histology based solely on its preoperative radiological characteristics. A neurosurgeon also predicted pathological findings based on preoperative imaging alone in the derivation data set. The 2 pathology predictions were compared using a kappa statistic; both estimates were also similarly compared with the actual pathological finding.
The primary outcome measure was hydrocephalus within 6 months of tumor diagnosis, as defined by the occurrence of either ventricular shunting or endoscopic third ventriculostomy.
Prediction Score Development
All statistical analyses were conducted using SAS version 9.1 (SAS Institute). Univariate analyses were conducted on all variables. Multivariate analysis was performed using forward stepwise logistic regression with the entry threshold set at a probability value < 0.05. Odds ratios for each variable were rounded to the nearest integer and adjusted using subjective interpretation of the quality of the data to establish each variable's numeric score in the clinical prediction rule. 31 For example, despite the variable "presence of papilledema" having a multivariate OR of 2.59, we subjectively modified its score to 1 as its data quality was weakened because 11.4% of patients had incomplete data. Despite this subjective manipulation, the scores remained in rough proportion to one another, similar to the statistically estimated ORs. The individual scores were summed to produce an overall score that we call the CPPRH.
An ROC curve was produced for each possible numerical value of the CPPRH, 6, 16 and the 95% CIs were calculated using bootstrapping. Calibration, "the level of agreement between the disease probabilities estimated by the model and the observed disease frequency," 13 was measured by the Hosmer-Lemeshow goodness-of-fit test. 19 Accuracy or the discriminative ability of the CPPRH was determined by calculating the area under the ROC curve.
Likelihood ratios represent the predictive ability and strength of a model in a more clinical context. A nonspecific (at the patient level) premodel probability of hydrocephalus (converted into a premodel odds) is multiplied by the appropriate likelihood ratio (score stratum) depending on the specific patient's characteristics. The output of this Bayesian calculation is a postmodel odds that is converted to a postmodel probability of hydrocephalus specific to that patient or any patient with a similar score. A useful prediction model demonstrates a progression of likelihood ratios across ascending strata within the score, 7, 28 which, in turn, demonstrates to the clinician that the proposed model can differentiate between clinically important and distinct subpopulations of patients, each of which has its own unique risk of postresection hydrocephalus.
The CPPRH was dichotomized into high-and lowrisk strata using the technique described by Weinstein and Feinberg. 32 Ratios of the relative consequences of falsepositive versus false-negative misclassifications were elicited from the same experts who participated in the qualitative study that identified potential predictors. These ratios were then averaged and reported as the impact factor used in the Weinstein method, 32 which weights the clinical consequences of both false positives and false negatives, then estimates the optimal cutoff score in the model, and which minimizes negative consequences.
External Validation
Because this prediction score was developed using data from a single center (Toronto), the model was tested on an independent sample to confirm its applicability and generalizability for all pediatric neurosurgery centers. Each patient in the validation (Vancouver) cohort was scored and assigned to a stratum, and the likelihood ratios and probabilities of postresection hydrocephalus for each stratum were calculated. An ROC curve, the area under the ROC curve, and the Hosmer-Lemeshow goodness-of-fit statistic were estimated for the validation cohort. The percentage of misclassification was measured when the CPPRH was dichotomized.
Prevalence Adjustment
The 2 cohorts of patients had similar characteristics except for the overall probability of the primary outcome. This suggested the need to adjust the predicted probabilities for the validation cohort to account for its much lower than expected rate of postresection hydrocephalus. 1, 4, 8, 12, 17, 18, 21, 24, 26 The unadjusted predicted probabilities of hydrocephalus for each stratum of the validation or any other cohort of similar patients are those calculated by the model (seen column 2 of Table 6 ). Adjusted predicted probabilities of hydrocephalus for each stratum of the validation cohort were calculated by multiplying the pretest odds specific to the Vancouver sample by the likelihood ratios from the model (Toronto sample). These unadjusted and adjusted predicted probabilities were then compared with the actual observed probabilities in the Vancouver cohort for each CPPRH stratum. 25 We refer to this as the Bayesian adjusted posttest predictions. Score levels with small cell sizes were collapsed to improve precision.
Results
Patient Characteristics
Clinical and radiological characteristics of both the derivation and validation cohorts are presented in Table 1 . Four children who died within 6 months of resection were excluded from the cohorts (3 and 1 in derivation and validation cohorts, respectively). All 4 presented in a moribund clinical state, and it is reasonable even in retrospect that the treating pediatric neurosurgeons might have anticipated their rapid demise (all within 1 month). Twelve of 343 patients from Toronto and 3 of the 111 patients from Vancouver did not have preoperative images available and were therefore eliminated from the multivariate analysis. The 2 cohorts were very similar in regard to all variables with 2 exceptions. The primary outcome, permanent CSF diversion at 6 months, occurred in 31.2 and 18.9% of the derivation and validation cohorts, respectively (p = 0.007). The qualitative degree of preoperative hydrocephalus also differed statistically between the cohorts (p < 0.001). However, when measured quantitatively, using either the FOHR (p = 0.17) or transependymal edema (p = 0.96), no difference in the degree of hydrocephalus was evident between the 2 cohorts.
Score Development Using the Derivation Cohort
All variables tested had significant univariate associations with the outcome (Table 2) , with the exceptions of tumor size (p = 0.74), tumor hemorrhage (p = 0.43), and a borderline association with the radiologist's estimation of pathology (p = 0.061). All variables were included in the derivation multivariate logistic regression.
The stepwise multivariate analysis identified 5 variables significantly associated with the primary outcome ( Table 2) : age < 2 years, the presence of papilledema, preoperative moderate or severe hydrocephalus, presence of cerebral metastases, and an estimated tumor pathology of medulloblastoma, ependymoma, or dorsally exophytic brainstem glioma. No significant interactions were identified. Tables 3 and 4 show the modified individual scores associated with each variable based on rounding and subjective judgment as described above and the predicted probabilities of postresection hydrocephalus at 6 months corresponding to each score stratum, respectively.
Model Evaluation
No significant outliers to the model were found. The prediction score calibrated significantly with a HosmerLemeshow statistic of 2.806 (p = 0.95), indicating that the disease (hydrocephalus) probabilities predicted by the model matched the observed disease frequency. The area under the ROC curve using the raw model (that is, the multivariate OR shown in Table 2 ) was 0.779 (95% CI 0.702-0.838), indicating that individual CPPRH scores can significantly discriminate the likelihood of developing postresection hydrocephalus. Using the final score values shown in Table 3 , the area under the ROC curve was 0.762 (95% CI 0.710-0.815).
The likelihood ratios for each stratum of the CPPRH for the derivation cohort are shown in the second column of Table 5 . These progressed from a low value of 0.283 (95% CI 0.175-0.461) for patients with scores of 0-2 to quite a high value of 6.098 (95% CI 3.300-11.324) for patients with scores 5 and higher. Using these generated likelihood ratios and a pretest probability of hydrocephalus of 31.2%, the overall score produced a predicted posttest probability of 11.4% for patients scoring 0-2 and 73.4% for those 5 or higher (Table 6) .
High-Risk Cutoff
Data generated from the qualitative study indicated that the consequences of a false-positive designation of high risk were 2.5 times more harmful those that of a falsenegative designation (the impact factor). A false-positive designation could potentially result in an unnecessary prophylactic surgery with inherent complications risks of up to 13.6%, 10 whereas a false-negative designation would only delay the diagnosis of hydrocephalus until after the tumor resection (identical to the current expectant management). Using this value as well as the pretest odds for the derivation cohort, the Weinstein technique 32 produced an optimal dichotomizing cumulative score of 5 or higher. Table  5 also shows the likelihood ratios associated with treating the CPPRH as a dichotomized variable. After the application of the cutoff, the CPPRH misclassified 25.1% patients (83 of 331) and had a sensitivity of 32.4% and a specificity of 94.7%.
External Validation of the Score Using the Validation Cohort
When applied to the validation cohort, the score retained significant calibration (Hosmer-Lemeshow 2.456, (Table 5) . Observed probabilities of postresection hydrocephalus in the Vancouver cohort varied from 13.9% for patients scoring 0-2 and 41.7% for those 5 or higher (Table 6 ). When dichotomized into risk strata, the score misclassified 21.3% patients (23 of 108) and had a sensitivity of 23.8% and a specificity of 92.0%.
External Validation Using Prevalence Adjustment
As a second statistical check on the validity of the Toronto derivation (Toronto) model on the validation (Vancouver) data, we used the likelihood ratios derived from Toronto and the pretest odds derived from Vancouver to calculate adjusted predicted posttest probabilities for the 
) NS
* Twelve patients have missing data for all radiological criteria because of unavailability of preoperative imaging. Abbreviation: NS = not significant. † Unless otherwise indicated. ‡ Radiological characteristics are based on 226 and 105 patients only in the no shunt and shunt required cohorts, respectively, because of the lack of availability of preoperative imaging in the remainder of the patients. § Qualitative measure of degrees of hydrocephalus was dichotomized into none/mild versus moderate/severe. ¶ Reference for logistic regression. Vancouver cohort. These are compared with observed probabilities at each stratum and are shown in Table 6 . The progression of posttest probabilities values shown in columns 3 and 4 are quite similar, indicating that, when adjusted for the validation cohort's low rate of postresection hydrocephalus, our model predicted hydrocephalus in these patients with even more accuracy and precision than when left unadjusted.
Comparison of Predicted and Actual Tumor Pathology
The kappa statistics measuring agreement between the neuroradiologists' and the neurosurgeon's predicted pathology and actual pathology were 0.480 (95% CI 0.419-0.537) and 0.680 (95% CI 0.649-0.710), respectively. This represents moderate agreement in the case of the neuroradiologist and substantial agreement in the case of the neurosurgeon. The most common prediction error was the distinction between ependymomas and medulloblastomas. Because these 2 diseases have the same individual score (see Table 3 ), this error has no effect on the overall CPPRH score.
Discussion
In this study, we amassed the largest single-study cohort (454 children) with posterior fossa tumors from 2 of Canada's largest pediatric neurosurgical centers. Using a derivation cohort of 343 patients, we were able to identify preoperative patient variables that predict posttumor resection hydrocephalus and integrate them into a simple prediction rule of hydrocephalus that we believe can be used prior to tumor resection by clinicians (Tables 3 and  4 ). The score was externally validated on an independent population of 111 patients.
In terms of the individual risk factors, a young age, 1, 4, 17, 18, 27 qualitative degree of hydrocephalus, 18, 21, 27 presence of metastases, 18 and tumor histology 1, 17, 21 have been previously noted in published reports to have an association with the need for permanent CSF shunting in this population. However, our study validated these individual variables (age < 2 years, degree of hydrocephalus, and intracerebral metastases) in combination with novel predictors such as papilledema and preoperative estimations of specific tumor pathological findings. This study confirms the predictive nature of these variables; however, the underlying physiological nature of these relationships can only be theorized with little supporting evidence from the basic science literature. Thus, the results might serve as research hypotheses for future basic science laboratory studies.
The CPPRH is shown to be an accurate predictor as evidenced by the areas under the ROC curves of 0.762 and 0.643 for the derivation and validation cohorts, respectively. As shown in Table 6 , the posttest probabilities for the high-and low-risk patients differed by 48% (that is, 73-25%) and 45% (that is, 59-14%) for the derivation and Bayesian adjusted validation samples, respectively. We believe that these differences in posttest probabilities between patients with high-and low-risk designations are clinically useful. This knowledge can be of value to the This study has several limitations. The subjectivity of the qualitative "degree of hydrocephalus" variable was evident, as the proportion of patients in each category differed significantly between the 2 cohorts (p = 0.011) while the distribution of patients in the categories using quantitative measures such as the FOHR did not (p = 0.168) ( Table 1) . To quantify this effect on our score, we repeated the logistic regression with the FOHR replacing the qualitative measure. The same final predictors with very similar ORs remained in the model with only a slight improvement in accuracy (area under the ROC curve of 0.791 vs the previous 0.779). Therefore, the effect of this subjectivity on the score itself was minimal. Hence, the ubiquity of this qualitative measure and the comfort clinicians have with it outweigh any minimal penalty to the score's accuracy.
The experts involved in the semistructured interviews concluded it was 2.5 times worse to perform a prophylactic shunt procedure in a patient who did not need one (false positive) than it was to require a delayed operation in one who did (false negative). Therefore, when we determined the high-risk cutoff, a premium was placed on high specificity for both the derivation and validation cohorts (94.7 and 92.0%, respectively) to minimize false positives; however, in so doing, we sacrificed sensitivity (32.4 and 23.8%, respectively), which was thought to be less consequential clinically.
The most dramatic difference between our 2 study cohorts was the chance of occurrence of the outcome, 31.2% in the derivation and 18.9% in the validation cohort. We were unable to account for this difference using any of the collected predictors or other variables such as surgeon, surgeon experience, and 5-year eras. Potential explanatory factors such as intraoperative or postoperative variables are worthy of future study. Regardless of the cause of this difference in prevalences, to confirm the external validation, an appropriate method for comparing predicted and observed probabilities of hydrocephalus was the Bayesian adjustment we performed in this paper. (This adjustment method requires that the distribution of predictor variables be similar in the derivation and validation cohorts, 22, 25 a condition that was met in this study [see Table 1 ].) Both the unadjusted and the adjusted predicted probabilities for hydrocephalus resembled (very closely, in the case of the adjusted) those observed in that validation cohort (Table 6) , Thus, the Bayesian adjustment served to further strengthen the external validation.
Conclusions
The primary goal of this study was to differentiate patients between high-and low-risk strata for either tailored treatment planning or for modifying the intensity of postoperative monitoring both clinically and radiologically for hydrocephalus. We believe we have met this threshold using the CPPRH we defined ( Table 3 ). The score can also be used upfront to preoperatively estimate individual risks of postresection hydrocephalus for patient counseling (Table 4 ). In the rare circumstance of an individual institution having a known or estimated baseline shunting rate significantly different from 30% (the worldwide average 1, 4, 8, 12, 17, 18, 20, 21, [23] [24] [25] [26] ), the prevalence adjustment may be used to generate more precise estimations of risk. Therefore, this validated preoperative prediction score can be incorporated into the neurosurgical care of any tertiary care pediatric hospital.
